Clinicopathological and Prognostic Features of Borrmann Type IV Gastric Cancer Versus Other Borrmann Types: A Unique Role of Signet Ring Cell Carcinoma

Overview

Journal Saudi J Gastroenterol

Specialty Gastroenterology

Date 2023 Jul 20

PMID 37470667

Authors

Chengcai Liang

Yao Liang

Biyi Ou

Lei Yuan

Shuqiang Yuan

Affiliations

Soon will be listed here.

Abstract

Background: Evidence specifically comparing the clinicopathology of Borrmann type IV (B-IV) gastric cancer with that of other Borrmann types is insufficient.

Methods: A total of 3130 patients with advanced gastric cancer who underwent gastrectomy from January 2001 to September 2017 were enrolled in the analysis. Logistic regression and survival analysis methodology were used to investigate factors associated with peritoneal metastasis and overall survival (OS).

Results: Of the total cohort, 264 (8.43%) patients were B-IV type, 1752 (55.97%) were small-size other Borrmann types, and 1114 (35.59%) were large-size other Borrmann types. Signet ring cell carcinoma (SRC) was more common in B-IV types than in other Borrmann types (33.71% vs 11.42% vs 12.66%, P < 0.001). In B-IV gastric cancers, SRC was significantly associated with peritoneal metastasis (HR = 1.898, 95% CI = 1.112 ~ 3.241, P = 0.019) and poorer OS (HR = 1.492, 95% CI = 1.088 ~ 2.045, P = 0.013) in multivariable analysis. Furthermore, stratified analysis revealed that SRC had worse survival than adenocarcinoma in the B-IV subgroups, with locally advanced stages (stages II ~ III) or negative surgical margins (all P < 0.05). In contrast, SRC failed to be significantly associated with peritoneal metastasis and poor OS in other Borrmann types (all P > 0.05).

Conclusion: SRC was more common in B-IV gastric cancer than in other Borrmann types. It was significantly associated with peritoneal metastasis and poorer OS in the B-IV type but not in other Borrmann types. As a unique prognostic factor for B-IV gastric cancer, SRC might help evaluate risk stratification and optimize treatment for this entity, especially for patients with locally advanced stages or R0 resection.

References

Blackham A, Swords D, Levine E, Fino N, Squires M, Poultsides G . Is Linitis Plastica a Contraindication for Surgical Resection: A Multi-Institution Study of the U.S. Gastric Cancer Collaborative. Ann Surg Oncol. 2015; 23(4):1203-11. PMC: 4980579. DOI: 10.1245/s10434-015-4947-8. View

Tan I, Ivanova T, Lim K, Ong C, Deng N, Lee J . Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology. 2011; 141(2):476-85, 485.e1-11. PMC: 3152688. DOI: 10.1053/j.gastro.2011.04.042. View

Ajani J, DAmico T, Almhanna K, Bentrem D, Chao J, Das P . Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016; 14(10):1286-1312. DOI: 10.6004/jnccn.2016.0137. View

Voron T, Messager M, Duhamel A, Lefevre J, Mabrut J, Goere D . Is signet-ring cell carcinoma a specific entity among gastric cancers?. Gastric Cancer. 2015; 19(4):1027-1040. DOI: 10.1007/s10120-015-0564-2. View

LAUREN P . THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965; 64:31-49. DOI: 10.1111/apm.1965.64.1.31. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2015. CA Cancer J Clin. 2015; 65(1):5-29. DOI: 10.3322/caac.21254. View

Huh C, Jung D, Kim J, Lee Y, Kim H, Kim H . Signet ring cell mixed histology may show more aggressive behavior than other histologies in early gastric cancer. J Surg Oncol. 2012; 107(2):124-9. DOI: 10.1002/jso.23261. View

Messager M, Lefevre J, Pichot-Delahaye V, Souadka A, Piessen G, Mariette C . The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study. Ann Surg. 2011; 254(5):684-93. DOI: 10.1097/SLA.0b013e3182352647. View

Heger U, Blank S, Wiecha C, Langer R, Weichert W, Lordick F . Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?. Ann Surg Oncol. 2014; 21(5):1739-48. DOI: 10.1245/s10434-013-3462-z. View

10.

Hass H, Smith U, Jager C, Schaffer M, Wellhauber U, Hehr T . Signet ring cell carcinoma of the stomach is significantly associated with poor prognosis and diffuse gastric cancer (Lauren's): single-center experience of 160 cases. Onkologie. 2011; 34(12):682-6. DOI: 10.1159/000334545. View

11.

Edge S, Compton C . The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010; 17(6):1471-4. DOI: 10.1245/s10434-010-0985-4. View

12.

Xu C, Guo J, Jiang Z, Xie S, Shen J, Shen J . Prognostic role of estrogen receptor alpha and estrogen receptor beta in gastric cancer. Ann Surg Oncol. 2010; 17(9):2503-9. DOI: 10.1245/s10434-010-1031-2. View

13.

Yoshida K, Yamaguchi K, Okumura N, Tanahashi T, Kodera Y . Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification. Gastric Cancer. 2015; 19(2):329-338. PMC: 4824831. DOI: 10.1007/s10120-015-0575-z. View

14.

Tang W, Liu R, Yan Y, Pan X, Wang M, Han X . Expression of estrogen receptors and androgen receptor and their clinical significance in gastric cancer. Oncotarget. 2017; 8(25):40765-40777. PMC: 5522298. DOI: 10.18632/oncotarget.16582. View

15.

Chiu C, Kuo C, Yeh T, Hsu J, Liu K, Yeh C . Early signet ring cell gastric cancer. Dig Dis Sci. 2010; 56(6):1749-56. DOI: 10.1007/s10620-010-1487-8. View

16.

Bonnot P, Piessen G, Kepenekian V, Decullier E, Pocard M, Meunier B . Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis. J Clin Oncol. 2019; 37(23):2028-2040. DOI: 10.1200/JCO.18.01688. View

17.

Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E . Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009; 125(3):666-73. DOI: 10.1002/ijc.24290. View

18.

Yang B, Wu G, Wang X, Zhang X . Discussion of modifying stage IV gastric cancer based on Borrmann classification. Tumour Biol. 2013; 34(3):1485-91. DOI: 10.1007/s13277-013-0673-7. View

19.

Gao K, Wu J . National trend of gastric cancer mortality in China (2003-2015): a population-based study. Cancer Commun (Lond). 2019; 39(1):24. PMC: 6498569. DOI: 10.1186/s40880-019-0372-x. View

20.

Zhang M, Zhu G, Zhang H, Gao H, Xue Y . Clinicopathologic features of gastric carcinoma with signet ring cell histology. J Gastrointest Surg. 2009; 14(4):601-6. DOI: 10.1007/s11605-009-1127-9. View